FDCTech Signs $25M Regulation S Subscription at $2.00/Share, Up to 20M Shares
Summary
FDCTech signed a $25 million Regulation S subscription with Quant Analytic Technologies, priced at $2.00 per share (floor $1.25) in eleven installments through September 2027, for up to 20 million shares. The first $8 million is escrowed, and no shares issue until the full commitment is funded.
Key Events · Financing and Capital Events · FDCT
-
$25M Regulation S Subscription Signed
Quant Analytic Technologies Inc., wholly owned by Oscar Hilt Tatum IV, irrevocably subscribed for $25,000,000 of common stock payable in eleven installments from November 13, 2026 to September 9, 2027.
-
Pricing Below Current Market
Each installment prices at $2.00 per share or the prior close if lower, floored at $1.25 — versus today's $4.00 price. At $2.00 the deal is 12,500,000 shares; at the $1.25 floor it is 20,000,000 shares, against 125,323,068 outstanding as of September 30, 2026.
-
Escrow and Funding Risk
The first two installments ($8,000,000, up to 6,400,000 shares) sit in escrow, and no shares are issued until the full $25,000,000 is received; the company bears the risk the investor stops paying.
-
Investor Governance Rights
The investor may nominate one independent director while it holds at least 5% of common stock, and holds pro rata participation rights on private equity issuances until the second anniversary, so long as it holds at least 4,000,000 shares.
Analysis · FDCT · Technology
FDCTech has locked in a $25 million equity commitment from a single offshore investor, Quant Analytic Technologies, to be paid in eleven installments through September 2027. Pricing is the detail that matters: $2.00 per share, or the market close if lower, but never below $1.25. Against today's $4.00 price, that strikes the shares well below where the stock trades, making the deal dilutive on terms favorable to the buyer. At the $2.00 cap the company issues 12,500,000 shares; at the $1.25 floor it issues 20,000,000, against 125,323,068 shares outstanding as of September 30, 2026 — roughly 10% to 16% dilution if fully drawn. The money is not in hand: only the first two installments ($8,000,000) are escrowed, and no shares are issued until the full $25,000,000 is received, so funding risk sits with the company. The investor also gets a board seat at 5% ownership and pro rata rights on future private raises, giving one outside holder real influence. This follows a Q3 that swung to a $6.3M net loss on a 37.5% revenue decline, so the capital addresses a real cash need.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FDCT was trading at $4.00 on OTC in the Technology sector, with a market capitalization of approximately $501.4M. The 52-week trading range was $0.13 to $10.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.